Global Ganja Report

Critical legislation that would allow the cannabis industry to access financial services has passed the Democratic-controlled House of Representatives for yet a sixth time—but will likely be killed once again by the Senate, where the Democratic majority is razor-thin.

Nearly 20 states have now approved initiatives or legislation to legalize cannabis, and demands are growing to wipe out past convictions for personal possession. Authorities in some of these states have started to respond—but things are not moving fast enough for advocates of a socially just model of legalization.

It's been a week since Senate Majority leader Chuck Schumer of New York, joined by Sen. Cory Booker (D-NJ) and Sen. Ron Wyden (D-OR), unveiled much-anticipated draft legislation to legalize cannabis at the federal level, calling it a "long overdue" move "to right the wrongs of the failed war on drugs." The proposed Cannabis Administration & Opportunity Act would remove the plant from the Controlled Substances Act, and allow states to craft their own cannabis policies as they do with alcohol. It would also create a federal regulatory framework and impose an excise tax for cannabis products. It includes measures that would expunge prior convictions and allow those serving time for applicable crimes to petition for resentencing.

As political and legal space opens for cannabis in state after state, the idea of caps on the potency — whether of flower, extracts or edibles — is gaining currency. But voices in the cannabis industry view this as a phobic response rooted in the flawed assumptions of prohibition.

At the annual Vienna meeting of the Commission on Narcotic Drugs, the governing body of the UN Office on Drugs & Crime (UNODC) voted Dec. 2 to strike cannabis from Schedule IV of the 1961 Single Convention on Narcotic Drugs, the global treaty regulating drug control policy.

Joe Biden's choice of running mate is Kamala Harris, who will bring a more progressive position on cannabis to the ticket. But if Harris today embraces legalization, she too has capitulated to the drug war establishment in the past—a reality her critics have been quick to exploit. A review of her record reveals an overall evolution toward a more enlightened stance.

Nancy Pelosi roused the ire of Mitch McConnell and anti-pot lobbyists when she defended inclusion of a measure to protect cannabis businesses in the House pandemic recovery bill. Does the science actually point to a therapeutic role for cannabis in treatment of COVID-19?

2019 saw advances for cannabis freedom on both the national and global stage—but also some near-misses, from New York state to Mexico, which have left activists frustrated if no less determined. As advocates prepare to carry the fight into 2020, here's a review of what was achieved—or almost achieved—over the past 12 months.